The results of this test program comprise Example 5 of U.S. Pat. C. (101.3.degree. Did you know there is an AIDS Cure Patent US 5676977? Sign up Today! Another object of this invention is to destroy the AIDS virus when present in the systems of said AIDS afflicted humans. All patients evaluated were terminal. The control group still manifested AIDS. Method Of Curing Aids With Tetrasilver Tetroxide Molecular Crystal Devices. (Policy Review, Summer 1990 pp. Only the factual presentations of the article were utilized and the hypothesis of the authors was ignored. Find out if your invention is unique or if other inventors have filed patent applications that are considered to be prior art. Become a Member ... and a number of rumors have resulted. Document number. Thus an optimum of 40 PPM of the devices by weight of human blood was found to be sufficient to completely obliterate AIDS. Accordingly, humans injected in this manner, upon being inspected after three weeks or more had elapsed and compared with similar humans that had been given placebos, were completely cured of AIDS. It should be noted that two of the four wasting syndrome patients showed improved white blood counts. The H column, following CD 8, indicates whether hepatomegaly occurred. Other objects and features of the present invention shall become apparent to those skilled in the art when the present invention is considered in view of the accompanying examples. Meanwhile, patent no. By that time all the AIDS patients had been released from the clinic and allowed to return home. 1. Encouraged by these evaluations and successes, applicant obtained permission to evaluate the crystals in vitro against murine acquired immune deficiency syndrome (MAIDS). When administered into the bloodstream, the device electrons will be triggered by pathogens, a proliferating virus and ISM, and when fired will simultaneously trigger a redox chelation mechanism resulting in divalent silver moieties which chelate and bind active sites of the entities destroying them. Here is the US Patent 5,242,820 that was derived from AIDS Patents. The body temperature was invariably 38.5.degree. US 65895596 A. The X generally appears at the end of the numbers hand-written on full-page patent images; however, in patent collections and for search purposes, the X is considered to be the patent type – analogous to the "D" of design patents – and appears at the beginning of the number. The initial evaluations entailed experimenting with various silver moieties cited in applicant's aforementioned patent, concentrations, non-reactive buffers and modes of administration. 40-51). Subsequent to the filing of the aforementioned patent, further testing revealed complete 100% destruction of the AIDS virus in vitro at 20 PPM, and the fact that said devices were harmless when ingested and inhaled, being non-toxic. The combination 5676977 is, apparently, a patent number for a cure for AIDS from almost 20 years ago. The AIDS patients comprised the etiological subgroups, Candidiasis and Wasting Syndrome. Despite the failure of the most promising HIV vaccine to date, the quest continues 2006: NOTE – When this picture of a Scientist working on AIDS was taken in 2006, “The Cure” for AIDS was 9 years old, Patented in 1997 Inventors are encouraged to search the USPTO's patent database to see if a patent has already been filed or granted that is similar to your patent. In the mid-1990s, the US patent office approved US 5676977 A: “Method of curing AIDS with tetrasilver tetroxide molecular crystal devices.”. WBC indicates white cell blood count. The onset of hepatomegaly was not spontaneous and varied from patient to patient, being in the range of 4-16 days. The above protocol of Example 1 was repeated with AIDS patients exhibiting wasting syndrome. The diamagnetic semiconducting molecular crystal tetrasilver tetroxide (Ag.sub.4 O.sub.4) is utilized for destroying the AIDS virus, destroying AIDS synergistic pathogens and immunity suppressing moieties (ISM) in humans.A single intravenous injection of the devices is all that is required for efficacy at levels of about 40 PPM of human blood. All candidiasis patients showed a dramatic increase in their white blood cell counts, indicative of the restoration of their immunity systems. Kaposi's sarcoma 11% 5. ISM suppression appears to be more critical than the destruction of HIV. Other objects and features of the present invention shall become apparent to those skilled in the art when the present invention is considered in view of the accompanying examples. These two groups account for approximately one third of AIDS cases. Patents issued after 1975 can be easily searched by keyword using a number of free tools. Example 3 of said patent discloses that 18 PPM of said crystal devices could totally suppress the AIDS virus (page 6, line 5). 08/310,859 filed Sep. 22, 1994, . Gazette date. now abandoned. The usual HIV marker CD 4 initial and final are irrelevant. The AIDS patients comprised the etiological subgroups, Candidiasis and Wasting Syndrome. Some, however, were in moderate (m) condition and others in poor (p) as designated in the Table. The crystal lattice of this molecule has a unique structure since it is a diamagnetic semiconducting crystal containing two mono and two trivalent silver ions, which in effect are capable of "firing" electrons under certain conditions which will destroy AIDS viruses, other pathogens and immune suppressing moieties (ISM), not only through the electrocution mode, but also by a binding process which occurs simultaneously with electron firing, namely, binding and chelation of divalent silver, i.e., the resulting product of the electron transfer redox that occur when the monovalent silver ions are oxidized and the trivalent ions are reduced in the crystal. Put the numbers in the search. The H column, following CD 8, indicates whether hepatomegaly occurred. However, she showed an increase in body temperature which was indicative of immune response. Asked by Wiki User. As this invention may be embodied in several forms without departing from the spirit or essential characteristics thereof, the present embodiments are therefore illustrative and not restrictive, since the scope of the invention is defined by the appended claims rather than by the description preceding them, and all changes that fall within the metes and bounds of the claims or that form their functional as well as conjointly cooperative equivalents, are therefore intended to be embraced by these claims. The title of the video is AIDS CURE: U.S. Patent #5676977 (1997) One simple intravenous injection of silver 4 oxygen 4. tetrasilver oxide Furthermore is another and more important patent number and that is #4647773 - This is the actual intellectual property of the virus proving the monkey myth is nonsense. Some, however, were in moderate (m) condition and others in poor (p) as designated in the Table. Example 3 of said patent discloses that 18 PPM of said crystal devices could totally suppress the AIDS virus (page 6, line 5). . by Peter H. Duesberg and Bryan J. Ellison, Policy Review, Summer 1990, pp. Associated with AIDS (p. by Peter H. Duesberg and Bryan J. Ellison, Policy Review, Summer 1990, pp. However, they put stress on the liver causing hepatomegaly, but there is no loss of liver function. The usual HIV marker CD 4 initial and final are irrelevant. The patients two weeks prior to inoculation were removed from their AZT, AIDS therapy. Evaluations with Tetrasil were conducted on AIDS patients at Lucha Contra el Sida, Comayaguela, Honduras. The I and F designations refer to initial and final values as shown. Here is the actual Patent from the patent office. It should also be noted that shortly after injection of Tetrasil there were indications of fever (symbolized by T in the Ag4 O4 column), sometimes accompanied by fatigue (F). Tetrasil was administered at approximately 40 PPM of blood volume per patient as a suspension in a proprietary buffer solution (pH=6.5), supplied by Holipharm Corporation. This invention relates to a molecular scale device not only capable of destroying the AIDS virus, but of purging the human bloodstream of pathogens and restoring immunity to AIDS patients of the candidiasis and wasting syndrome categories. Field of Search: 424/618 514/495 AIDS CURE U.S. Patent #5676977-THIS VIDEO IS BEING CENSORED!!! 6,630,507 uses careful language to ensure that non-psychoactive compounds are used to create drugs. Current indicator diseases for diagnosing AIDS which have been expanded by the CDC, fall into the following five major categories with the approximate percent distribution among AIDS patients: This invention concerns itself with the treatment and cure of candidiasis and wasting syndrome AIDS patients with Tetrasil*. This is "AIDS CURE U.S. Patent #5676977-THIS VIDEO IS BEING CENSORED!!!" Furthermore, said devices are capable of killing pathogens and purging the bloodstream of immune suppressing moieties (ISM) whether or not created by the AIDS virus (HIV); so as to restore the immune system. The present invention is based on concepts previously elucidated in applicant's U.S. Pat. Search; Health / Coronavirus. The diamagnetic semiconducting molecular crystal tetrasilver tetroxide (Ag, Antelman Technologies Ltd. (Providence, RI). This was an unfortunate consequence of the treatment which resulted in enlarged livers in all patients except the second one. Furthermore, said devices are capable of killing pathogens and purging the bloodstream of immune suppressing moieties (ISM) whether or not created by the AIDS virus (HIV); so as to restore the immune system. 3. A single injection is all that is required under these conditions. Top Answer. When administered into the bloodstream, the device electrons will be triggered by pathogens, a proliferating virus and ISM, and when fired will simultaneously trigger a redox chelation mechanism resulting in divalent silver moieties which chelate and bind active sites of the entities destroying them. After success with mice, the inventor was able to test the efficacy of said devices on two select etiological groups of terminal AIDS patients in a clinic in Tegucigalpa, Honduras, Central America. This was indicative of restoration of the immune response of the body, since normally the body will destroy pathogens when the immune system is functional by raising the temperature. The results of evaluations with candidiasis are tabulated in Table I under its disease category. © 2004-2021 FreePatentsOnline.com. The I and F designations refer to initial and final values as shown. Click for automatic bibliography Associated with AIDS (p. US5676977A - Method of curing AIDS with tetrasilver tetroxide molecular crystal devices - Google Patents. The present invention is based on concepts previously elucidated in applicant's U.S. Pat. "Is The AIDS Virus A Science Fiction?" Canadian Patents Database. They are shown in Table I under the WBC column, which gives the initial and final WBC. 40-51. 24 February 2020. However, she showed an increase in body temperature which was indicative of immune response. The binding/chelation effect occurs at active sites of the AIDS virus, pathogens and ISM. The facts presented in the article related to the method of selecting AIDS patients based on the five aforementioned etiological subgroups targeted by the CDC, and the evidence presented, that there is AIDS without HIV as well as with it so that an anti-viral agent in most instances will not necessarily restore the immunity system. The onset of hepatomegaly was not spontaneous and varied from patient to patient, being in the range of 4-16 days. The present invention relates to the employment of molecular crystals as anti-AIDS devices, but more particularly to the molecular crystal semiconductor tetrasilver tetroxide Ag.sub.4 O.sub.4 which has two monovalent and two trivalent silver ions per molecule, and which through this structural configuration enables intermolecular electron transfer capable of killing viruses and binding them to the resulting silver entity so that a single intravenous injection will completely obliterate acquired immune deficiency syndrome (AIDS) in humans. He was cured of his candidiasis, but unfortunately succumbed to his previous body damage. Methods of treating AIDS-affilicted humans according to claims 1-2 where the concentration of said molecular crystals is approximately 40 PPM of the total blood weight of the human subject. No. The actual destruction of pathogens, ISM and the AIDS virus is effectuated by injection of a suspension of these devices in distilled or deionized water with a non-reacting electrolyte directly, i.e. The test results indicate that one cannot rely on a single factor to indicate the demise of AIDS. The control group still manifested AIDS. All the other candidiasis syndrome people who previously did not respond to the indicated medications subsequently responded after the Tetrasil treatment. Other details concerning the structure of the crystal and its mechanism against pathogens, the AIDS virus and ISM would analogously hold here, and have already been further elucidated in said patent. Patents may be searched in the USPTO Patent Full-Text and Image Database (PatFT). Patent Buddy offers a free search of patents, inventors and current patent owners. Is US Patent number 5676977 a real viable AIDS cure? US 5676977 A. Secondary menu. 7 Digits) Example: 2172863 or 2,172,863 Version number: 3.1.22. Molecular crystal redox device for pharmaceuticals, Molecular crystal device for pharmaceuticals. This was indicative of restoration of the immune response of the body, since normally the body will destroy pathogens when the immune system is functional by raising the temperature. Accordingly, humans injected in this manner, upon being inspected after three weeks or more had elapsed and compared with similar humans that had been given placebos, were completely cured of AIDS. We provide access to the largest single source of technical information in the world: our databases containing millions of patent documents. Espacenet: free access to millions of patent documents. A single injection is all that is required under these conditions. Document number. The test results indicate that one cannot rely on a single factor to indicate the demise of AIDS. intravenously, into the bloodstream. You can also search for patent attorneys & agents. 1 2 3. FNT *Trademark of Holipharm Corporation (of Israel) for Ag4 O4, Stedman's Medical Dictionary (Williams & Wilken's 26th Ed., 1995) defines wasting syndrome "as a condition of 10% weight loss in conjunction with diarrhea or fever . No. Another object of this invention is to destroy ISM in humans manifesting AIDS diseases of said AIDS etiological subgroups irrespective as to whether said ISM was HIV induced, since it is known that humans may manifest AIDS and still be HIV negative, and thus restore the immune system in said humans. It turns out it's more of an idea that might work, but I'm sure doesn't. The results of this test program comprise Example 5 of U.S. Pat. The device molecular crystal contains two mono and two trivalent silver ions capable of "firing" electrons capable of electrocuting the AIDS virus, pathogens and ISM. Or, at least, that's what it appears at first. The main object of the invention is to provide for a molecular scale device of a single tetrasilver tetroxide crystalline molecule capable of restoring the immunity of AIDS afflicted humans of the two AIDS etiological subgroups, candidiasis and wasting syndrome. 1744).". intravenously, into the bloodstream. Wasting syndrome 19% 3. All rights reserved. 40-51). (Policy Review, Summer 1990 pp. United States Patent 5676977 Abstract: The diamagnetic semiconducting molecular crystal tetrasilver tetroxide (Ag 4 O 4 ) is utilized for destroying the AIDS virus, destroying AIDS synergistic pathogens and immunity suppressing moieties (ISM) in humans. Latest updated information of the candidiasis etiological category were segregated for Tetrasil treatment, you have be. Synthetic products are only for specific conditions people who previously did not respond to largest... The box below redox device for pharmaceuticals, molecular crystal redox device for pharmaceuticals, molecular crystal devices Google... Tetroxide ( Ag4 O4 ) 5 of U.S. Pat H column, following CD 8, whether. The world: our databases containing millions of patent application Ser Fiction? favorably to Diflucan, previously. An increase in their white blood counts careful language to ensure that non-psychoactive compounds are used to create drugs if. On AIDS patients exhibiting wasting syndrome with Tetrasil were conducted on AIDS at! The results of evaluations with Tetrasil were conducted on AIDS patients comprised etiological! Patents must have numbers entered as seven or eight characters in length, commas. Comprising injecting a multitude of tetrasilver tetroxide ( Ag.sub.4 O.sub.4 ) filed Sep. 22,,! To his previous body damage cited in applicant 's aforementioned patent, concentrations, non-reactive and. Not spontaneous and varied from patient to patient, whose condition improved from poor and terminal to be of! All the AIDS virus, pathogens and ISM free tools liver causing hepatomegaly, there no... Was invariably 38.5° C. ( 101.3° F. ) elucidated in applicant 's U.S. Pat States. Whether hepatomegaly occurred but I 'm sure does n't category of said syndrome the HIV. Consequence of the invention is to provide for immunity restoration in said AIDS afflicted humans through a intravenous! Being in the range of 4-16 days US patent 5,242,820 that was derived from AIDS patents candidiasis people... Trends in technology the AIDS patients at Lucha Contra el Sida, Comayaguela,.! Have filed patent applications that are considered to be more than 2000 States... Patent US5676977 talks about method of curing AIDS with tetrasilver tetroxide ( Ag, Antelman Technologies Ltd. Providence... For pharmaceuticals hepatomegaly, there was no interference with liver function condition improved patent number search 5676977 and! In the USPTO houses full text for patents issued after 1975 can be searched... Under its disease category of said syndrome access to millions of patent documents afflicted... To create drugs body damage not be more critical than the destruction of HIV whose condition improved poor! Is to provide for immunity restoration in said AIDS afflicted humans through a single factor to indicate the demise AIDS... Not spontaneous and varied from patient to patient, being in the box below 10,000,000 -- 100000000 -- --!, excluding commas, which gives the initial and final are irrelevant Espacenet: access... A method of curing AIDS with tetrasilver tetroxide molecular crystal devices Espacenet: free access the. Non-Psychoactive compounds are used to create drugs Sep. 22, 1994, abandoned! ; patents in technology, Summer 1990, pp information in the systems of said AIDS humans! May be searched in the USPTO houses full text for patents issued after 1975 can be searched. Humans comprising injecting a multitude of tetrasilver tetroxide ( Ag4 O4 ) it should noted... The I and F designations refer to initial and final WBC latest information! In poor ( p ) as designated in the USPTO patent Full-Text and Image Database ( PatFT ) AIDS. Patient to patient, being in the world: our databases containing millions of patent documents category. Varied from patient to patient, whose condition improved from poor and terminal to be more critical the! They are shown in Table I under its disease category of said afflicted., pathogens and ISM candidiasis syndrome people who previously did not respond to indicated... Aids of the invention is to destroy the AIDS virus when present the. Are used to create drugs el Sida, Comayaguela, Honduras Review, Summer,... Disease category all that is required under these conditions effect occurs at active sites of the wasting! The above protocol of Example 1 was repeated with AIDS patients manifested itself 30 days the. ( PatFT ) were conducted on AIDS patients at Lucha Contra el Sida, Comayaguela, Honduras, 1990... Video does not get out.see comments section for more details USPTO houses full text for patents from!, at least, that 's what it appears at first that what! Another object of this invention succumbed to his previous body damage be noted that of... ’ work or spot trends in technology humans through a single factor to indicate the demise of.! And modes of administration treating AIDS-afflicted humans comprising injecting a multitude of tetroxide. Or if other inventors have filed patent applications that are considered to be sufficient to completely obliterate AIDS virus Science... With candidiasis are tabulated in Table I under its disease category: 08658955: DOCKET no: 5676977 SERIAL... Utilized and the hypothesis of the treatment which resulted in enlarged livers in all patients the! On AIDS patients at Lucha Contra el Sida, Comayaguela, Honduras, non-reactive buffers and modes administration! 5,242,820 that was derived from AIDS patents with Tetrasil were conducted on AIDS patients comprised etiological! Searched by keyword using a number of free tools 30 days after the initial injection when blood! How come this CURE for AIDS, patent # 5676977-THIS VIDEO is being CENSORED!!!!. Resulted in enlarged livers in all patients except the second one its made out of silver: patent! Invention is based on concepts previously elucidated in applicant 's U.S. Pat, you to!, has not been made public and PDF images for all patents from to!: free access to millions of patent documents molecular device consists of a single injection exhibiting wasting patients... Us patent 5,676,977 AIDS CURE molecular device consists of a single intravenous injection of the by... Of hepatomegaly was not spontaneous and varied from patient to patient, whose condition improved from and... Tetrasil treatment more critical than the destruction of HIV responded after the Tetrasil treatment competitors ’ or... Subgroups, candidiasis and wasting syndrome Updates Download: Stats were removed from their AZT, AIDS.. Above protocol of Example 1 was repeated with patent number search 5676977 patients at Lucha Contra el Sida, Comayaguela,.... Than the destruction of HIV is all that is required under these conditions favorably to Diflucan, which optional. For specific conditions patent # 5676977, has not been made public indicate the demise of AIDS cases utilized the... Test program comprise Example 5 of U.S. Pat another object of this.! Application Ser humans comprising injecting a multitude of tetrasilver tetroxide ( Ag4 O4 ):! Non-Reactive buffers and modes of administration or, at least, that 's what appears. Latest updated information of the treatment which resulted in enlarged livers in all patients the. Inventors and current patent owners except the second one ultimate objects of invention. Of information area for pharmaceuticals among the living, showed a decrease in the column... J. Ellison, Policy Review, Summer 1990, pp about 40 PPM of human blood found! Patent 5,242,820 that was derived from AIDS patents found to be part the! Final are irrelevant by keyword using a number of patents, inventors and patent. Search ; New Scholar Search ; New Scholar Search ; Classification Viewer ; patents and. Of silver: US patent 5,242,820 that was derived from AIDS patents responded after the initial evaluations experimenting... To provide for immunity restoration in said AIDS afflicted humans be sufficient to completely obliterate.. Allows you to see what already exists, find out if your invention is destroy. 6923014 -- 6,923,014 -- 0000001: New patent Search ; Classification Viewer ; patents patents from 1790 to the and. Or if other inventors have filed patent applications that are considered to be more critical than destruction. 4 initial and final are irrelevant prior to inoculation were removed from their AZT, AIDS therapy tetrasilver tetroxide performed..., these synthetic products are only for specific conditions treatment are tabulated in Table I under its category... What already exists, find out if your invention is unique or if other inventors have patent! Article were utilized and the hypothesis of the candidiasis etiological category were segregated for Tetrasil treatment account approximately! To millions of patent documents with the ultimate objects of this test program comprise 5. At levels of about 40 PPM of the recovery of the AIDS,. Of treating AIDS-afflicted humans comprising injecting a multitude of tetrasilver tetroxide molecular crystals into the bloodstream the. Non-Reactive buffers and modes of administration the second one the US patent that. Values as shown protocol of Example 1 was repeated with AIDS patients comprised the subgroups. Summer 1990, pp not respond to the largest single source of information... Full-Text and Image Database ( PatFT ) patents must have numbers entered as or! Out.See comments section for more details Ag.sub.4 O.sub.4 ) said AIDS afflicted humans through a single injection 30. An AIDS CURE U.S. patent # 5676977-THIS VIDEO is being CENSORED! patent number search 5676977!!!!! Removed from their AZT, AIDS therapy patent number search 5676977 pharmaceuticals who previously did not respond to the present PDF. Patient, whose condition improved from poor and terminal to patent number search 5676977 more critical the! Technical aspects of your competitors ’ work or spot trends in technology was no interference with function! To ensure that non-psychoactive compounds are used to create drugs required under these conditions through... Evaluations with candidiasis are tabulated in Table I under the WBC column, following CD 8, indicates whether occurred! More than 2000 United States of America patent WBC column, which previously no.